Xtandi is a synthetic non-steroidal antiandrogen (NSAA) that is supplied in 40 mg standard dosage strength. It was developed for the treatment of men with metastatic castration-resistant prostate cancer. In August 2012, the xtandi 40 mg was approved by the U.S. Food and Drug Administration (FDA). Prostate cancer is marked by an out-of-controlled (malignant) progression of cells in the prostate gland. The prostate is the walnut-sized gland in men, situated below the bladder and in front of the rectum, surrounding the urethra which is a kind of tube that carries urine out of the bladder. It is also called prostatic carcinoma. Please contact us at 1800-889-1064 or send your enquiry at info@ikrispharmanetwork.com to check the best price of xtandi 40 mg in India with us.
0
